Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lynlee M Muehring
066 Avxs-101 Gene-Replacement Therapy (GRT) for Spinal Muscular Atrophy Type 1 (SMA1): Pivotal Phase 3 Study (STR1VE) Update
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Related publications
014 AVXS-101 Gene-Replacement Therapy (GRT) in Presymptomatic Spinal Muscular Atrophy (SMA): Study Update
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
P.065 AVXS-101 Gene-Replacement Therapy (GRT)) in Presymptomatic Spinal Muscular Atrophy (SMA): Study Update
Canadian Journal of Neurological Sciences
Medicine
Neurology
Psy16 - Health Outcome Improvements in Spinal Muscular Atrophy Type 1 Patients With Avxs-101 Gene Replacement Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Psy18 - Rapid Improvements in Motor Function in Spinal Muscular Atrophy Type 1 Following Avxs-101 Gene Replacement Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Spinal Muscular Atrophy Type 1
Pediatric Critical Care Medicine
Child Health
Critical Care
Pediatrics
Perinatology
Intensive Care Medicine
P.060 Time to Treatment Effect in Spinal Muscular Atrophy Type 1 (SMA1): An Indirect Comparison of Treatments
Canadian Journal of Neurological Sciences
Medicine
Neurology
AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study With a Prospective Natural History Cohort
Journal of Neuromuscular Diseases
Neurology
Gene Therapy in Mouse Models of Spinal Muscular Atrophy :||Using SMN Gene Replacement to Address Biological Questions
Respiratory Management of the Infant With Type 1 Spinal Muscular Atrophy
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology